neurons. Remarkably, by gestational week 28, the number of neurons in the human fetal brain is 40% greater than that in the adult [3] [4] [5] [6] . The rate of synaptogenesis reaches an astonishing peak so that at gestational week 34 to 24 months post-partum, there is an increase of 40,000 synapses per second [7] . Thus, prenatal life is a time of enormous neurological change and because of that the fetal nervous system is principally susceptible to programming influences.
The basic assumption of the fetal programming model of disease is that developing organisms, including the human fetus, play a dynamic role in their own construction [8] . One example of this is the adjustment made by the tadpole in response to stress [9] [10] [11] . The desert-dwelling Western spadefoot toad lays its eggs in desert rainwater. If the developing tadpoles detect that the conditions for normal development and survival are unfavorable (e.g., rapid evaporation of the pool), stress hormones including corticotrophin-releasing hormone (CRH) and corticosterone (glucocorticoids) are released. These hormones influence metabolism and accelerate metamorphosis, so that the tadpole can escape the desiccating environment and avoid impending peril. If the biological stress response is blocked during this life-threatening stress, the rate of development is arrested, and the tadpole's survival is compromised. There are penalties for the tadpole that survives under these conditions, however, because it is smaller at maturity and is at a disadvantage when competing with a normally developing toad foraging for food or reproducing.
Variations of this remarkable surveillance and response system are conserved so that many species, including the human fetus, can detect threats and adjust their development [10, 12, 13] . The human placenta is both a sensory and effector organ that incorporates and transduces information from its maternal host environment into the fetal developmental program. Early detection by the fetal/placental unit of stress signals from the maternal environment 'informs' the fetus that there is a threat to survival. The placental/fetal unit responds to this information in an unusual but adaptive way. In contrast to the inhibitory influence on the promoter region of the CRH gene in the hypothalamus (i.e., negative feedback), maternal stress signals (glucocorticoids) activate the CRH promoter region in the placenta, stimulate its synthesis, and advance the placental clock, resulting in myometrial activation and fetal escape (premature birth) from a malignant environment [14, 15] . In parallel, the fetus adjusts its developmental trajectory and modifies its nervous system to ensure survival in a potentially hostile postpartum environment. Survival under these circumstances, as described below, is associated with compromised motor, cognitive and emotional function [16, 17] and reduced brain gray matter volume [18] [19] [20] .
The 'fight or flight' stress system
The 'fight or flight' stress system is profoundly altered during human pregnancy. The fight or flight response first described by Cannon characterizes the reaction of organisms to threat [21] . When the human fight or flight response is triggered, sequences of nerve cell firing are activated, and chemicals are released into the bloodstream. These responses cause the body to undergo a series of very dramatic changes (Box 1), which intensify awareness, sharpen sight, quicken impulses, provide a burst of energy, exaggerate fear, focus attention and diminish the perception of pain. All of these responses are adaptive when an organism is threatened because they prepare for fight or flight and increase the probability of survival.
Box 1 Changes in the body associated with the fight or flight response
• Heart rate and blood pressure increase. The heart pump rate increases from 1 to 5 gallons per minute, arteries constrict to maximize pressure and veins open out to ease return of blood to the heart
• Veins in skin constrict to send more blood to major muscle groups. Pupils dilate to take in as much light as possible to improve vision
• Hairs stand on end, making us more sensitive to the environment
• Fat from fatty cells and glucose from the liver are metabolized to create instant energy
• Muscles tense up, energized by adrenaline and glucose
• Smooth muscles relax to allow more oxygen into the lungs
• Lungs, throat and nostrils open up and breathing speeds up to get more air into the system, so blood flow can be reoxygenated. The blood carries oxygen to the muscles, allowing them to work harder
• Blood vessels to the kidney and digestive system are constricted, effectively shutting down systems that are not essential. Shunted blood is directed to muscles and limbs to provide energy for fight or flight
• Reduction of saliva in the mouth
• The bowels and bladder may open to reduce the need for other internal actions
• Blood vessels to the skin are constricted to reduce potential blood loss
• Sweat glands are opened to provide an external cooling
• Stress hormones are released Selye recognized, however, that the fight or flight system could become maladaptive and lead to disease if it was chronically activated or if it responded to modern-day, non-lifethreatening stressors (rather than the challenges experienced by primitive man or by organisms with natural predators) [22] . His theory of the general adaptation syndrome was characterized by an alarm reaction or shock phase in the immediate response to stress or threat, a stage of resistance to maintain safety and health and finally, if defenses failed, an exhaustion stage placing the organism at risk for ill health. An inadequate response or exhaustion of the endocrine system to stress and threat was central to Selye's theory, and he proposed that it resulted in 'wear and tear on the body' [23] .
Endocrine fight or flight system
Systemic stress activates the expression of the master stress hypothalamic hormone, CRH, which stimulates the cascade of events preparing the organism for 'fight or flight.' CRH, a 41-amino-acid neuropeptide, is synthesized primarily in the paraventricular nucleus (PVN) of the hypothalamus and has a major role in regulating pituitary and adrenal function and the physiological response to stress [24, 25] . CRH stimulates the synthesis of a bioinactive 31 kDa pro-hormone, pro-opiomelanocortin in the pituitary, which is converted by enzymes into adrenocorticotropic hormone (ACTH) and other active peptides. ACTH enters the bloodstream and elicits secretion of glucocorticoids (cortisol in humans) from the adrenal gland. The negative feedback between the adrenal gland and both the hypothalamus and pituitary gland shuts down the endocrine stress response under normal conditions. In addition, cortisol crosses the blood-brain barrier and activates specific receptors in limbic brain structures and in the cortex. The limbic structures, especially the hippocampus, prefrontal cortex (PFC) and amygdala, have both excitatory and inhibitory connections with the hypothalamic-pituitary-adrenal (HPA) axis [26] .
Stimulation of the amygdala promotes synthesis and release of CRH from the hypothalamus and begins the sequence of events, that ultimately results in corticosteroid biosynthesis and secretion in the adrenal gland. In contrast to the amygdala, activation of the hippocampus terminates the HPA axis responses to stress. Hippocampal lesions are associated with basal hypersecretion of glucocorticoids [27] , enhanced basal CRH mRNA expression [28, 29] , increased ACTH secretion in PVN neurons and prolonged cortico sterone and ACTH release following exposure to a variety of stressors [30, 31] . The PFC also plays an important role in negative-feedback regulation of the HPA axis [32] . Studies in rats [33] [34] [35] and humans [36, 37] show that the PFC is a significant target for the negative-feedback actions of circulating corticosteroids. Direct implants of corticosterone into the medial prefrontal region decrease stress-induced ACTH and corticosterone secretion following acute or repeated restraint [38, 39] . Administration of CRH enhances CRF1 RNA expression throughout the medial PFC. There is evidence that the CRH peptide interacts with CRH neurons in the PFC to inhibit the HPA axis via indirect pathways, reducing CRH release from the PVN [40] .
Alterations of the endocrine fight or flight system during pregnancy
The endocrine stress or fight or flight system is profoundly altered during human pregnancy. The maternal pituitary gland doubles in size, and the output of peptides and hormones from the HPA and placental axis increases several fold as gestation progresses ( Figure 1 ). However, it is the growth and development of a new organ, the placenta, in primates that is primarily responsible for the profound changes in the stress circuit. The human placenta and amniotic membrane express the genes for the major stress hormones CRH (hCRH mRNA) and pro-opiomelanocortin by the seventh week of gestation. As presented in Figure 2 , all of the HPA and placental stress hormones increase as pregnancy advances, but the increase in placental CRH in maternal plasma is especially remarkable, reaching levels observed only in the hypothalamic portal system during physiological stress [41] . The levels of hCRH mRNA increase more than 20-fold in the 5 weeks preceding delivery [42] , resulting in a significant elevation in maternal CRH plasma concentrations during the second half of pregnancy [15] . Levels rise exponentially as pregnancy advances, peaking during labor and falling to very low or undetectable levels within 24 h after delivery [43] [44] [45] [46] [47] .
Placental CRH is identical to hypothalamic CRH in structure, immunoreactivity and bioactivity [48, 49] ; however, in contrast to the inhibitory influence on the promoter region of the CRH gene in the hypothalamus, maternal stress signals (cortisol) from the adrenal glands activate the promoter region in the placenta and stimulate the expression of hCRH mRNA. This establishes a feedback loop that results in the simultaneous stimulation, synthesis and release of cortisol, ACTH and CRH over the course of gestation ( Figure 2 ). The different, nearly opposite, activities of the CRH gene in the placenta and hypothalamus are because of the expression of different transcription factors, coactivators and corepressors in these two tissues [50] . The increase of CRH especially over the latter part of human gestation plays a fundamental role in the organization and programming of the fetal nervous system [51] , influences the timing of the onset of spontaneous labor and delivery [14, 15, [52] [53] [54] , and alters maternal adaptation during pregnancy, including dampening the effects of psychological stress [55] .
Endocrine risk
The human placenta integrates numerous sources of maternal stress signals, including cortisol, and responds with a dose-dependent release of placental CRH. The surge in placental CRH is produced by syncytial cells (which can be created in vitro by fusion of purified cytotrophoblast cells) [49] . As described above, there is a positive or feed-forward loop between maternal cortisol and placental CRH, in contrast to the negative-feedback system controlling hypothalamic CRH synthesis and release. The positive relationship between cortisol and CRH release from the placenta is similar to the stimulating effect of cortisol on the amygdala release of CRH [56] . In placental tissue, glucocorticoids stimulate CRH gene expression by interacting with proteins that bind to the cAMP response site of the CRH promoter [57] .
Evidence suggests that the normal trajectory of placental CRH production over the course of gestation may be accelerated by an adverse intrauterine environment characterized by physiological stress. For example, elevated placental CRH has been observed in pregnancies complicated by preeclampsia, reduced utero-placental perfusion, intrauterine infection and in cases where fetal distress has led to elective preterm delivery [58] . A series of in vitro studies have shown that CRH is released from cultured human placental cells in a doseresponse manner in response to all the major biological effectors of stress, including cortisol, catecholamines and proinflammatory cytokines [49, 59, 60] . The authors have in vivo evidence in humans that elevated levels of maternal cortisol early in gestation are associated with a more rapid rise in placental CRH concentrations [15] . Not only is placental CRH responsive to stress-related increases in maternal cortisol, but the administration of synthetic glucocorticoids for fetal lung maturation in pregnant women at risk for preterm delivery is similarly associated with significant increases in circulating placental CRH. Placental CRH concentrations increase by 1.5-fold within 12 h in response to the administration of synthetic glucocorticoids, such as betamethasone [61, 62] .
The placental detection of stress or adversity results in a rapid rise in CRH and primes or advances the 'placental clock' and begins the cascade of events influencing myometria [54] and in extreme cases, precipitating preterm birth. Moreover, placental CRH has been shown to increase the placental production of estrogens and to inhibit the synthesis of progesterone [63, 64] . Placental CRH is additionally released into the fetal compartment, where it stimulates the fetal adrenal to release dehydroe-piandrosterone sulfate, an obligate precursor for placental estriol production [65] . Alterations in the production of progesterone and estriol may be one pathway by which placental CRH regulates the timing of delivery [66] .
There is evidence that it is the trajectory of placental CRH and other hormone production over gestation, rather than their absolute concentrations, that best predicts preterm delivery, suggesting that target cells are highly responsive to relative changes in circulating concentrations. The effects of HPA and placental axis hormones on gestational length are modulated further by the activities of binding proteins and enzymes. For example, concurrent with increases in circulating levels of placental CRH, a CRH-binding protein (CRH-BP) is produced in the liver and also in the trophoblast and intrauterine tissues during pregnancy, and binds to circulating CRH, reducing its biological action [67] [68] [69] . In contrast to the increasing levels of circulating placental CRH over the course of gestation, CRH-BP levels are constant in the first, second and early third trimester (and are not significantly different from nonpregnant levels), but fall by approximately 30% as birth approaches [70] . The consequence of these changes in the levels of CRH and CRH-BP is a large increase of free and bioactive CRH during the last part of gestation. Maternal plasma cortisol-binding globulin (CBG) levels also increase progressively with advancing gestation until the end of gestation, when there is a significant decline in CBG leading to an increase in bioactive cortisol [71] . Moreover, levels of placental 11β-HSD2 (which oxidizes cortisol into its inactive form, cortisone) also increase as gestation progresses before falling abruptly near term ( Figure 3 ) [72] . The decrease in CBG and the decrease in the activity of placental 11β-HSD2 toward the end of gestation increase fetal exposure to maternal cortisol, ensuring maturation of the fetal lungs, CNS and other organ systems in full-term births [73, 74] . These exposures to elevated cortisol toward the end of gestation are normative and necessary for fetal maturation. Excessive exposures such as in the case of maternal stress or synthetic glucocorticoid treatment, however, are detrimental. Maternal stress may result in fetal exposure to excess cortisol both by increasing cortisol production and downregulating the activity of 11β-HSD2 [75] .
Evidence for prenatal exposure to elevated HPA influences on health outcomes
There is compelling evidence from both animal and human studies that exposure to excess glucocorticoids during the prenatal period is a risk factor for adverse neurodevelopmental outcomes, including suppressed growth [76] [77] [78] [79] [80] , HPA axis dysregulation [81] [82] [83] [84] [85] , increased fear and anxiety [86] [87] [88] [89] , and impaired cognitive functioning [87, 90, 91] . There is evidence from animal models that prenatal treatment with synthetic glucocorticoids has persisting and programming effects on brain development [92] [93] [94] [95] [96] [97] .
Exposure to stress and manipulations that elevate CRH, including exogenous administration, particularly early in development, have pervasive programming consequences for both brain and behavior [98] . CRH affects the developing brain directly due to extensive expression of CRH receptors throughout the brain [99] , as well as through effects on the fetal HPA axis [100] . CRH has neurotoxic effects on hippocampal neurons [101] [102] [103] [104] [105] ; effects that are more pronounced in the immature brain [103, 104, 106] and be prevented by selective blockade of the CRH 1 can receptor [107] . Furthermore, exogenously administered CRH increases limbic neuronal excitation leading to seizures [108] [109] [110] and participates in mechanisms of neuronal injury [103] .
Consistent with the clear evidence that elevated concentrations of CRH impair the developing brain in animal models, the authors present recent evidence that prenatal exposure to elevations in maternal stress hormones influences the maturation of the human fetal nervous system with long-term consequences for child development. These data suggest that fetal exposure to maternal stress hormones shape or program the developing fetal nervous system with consequences for impaired stress regulation, fearful temperament, neuromotor functioning and brain development.
Our approach
The research team has been exploring the consequences of early and gestational exposures in animal and human models to endocrine markers of stress for over 30 years and have concluded that fetal exposure to maternal and placental hormones has a lasting influence on neurological function [8, 55, 111, 112] . These initial studies were among the first to describe the long-lasting (perhaps permanent and programming) effects of fetal and neonatal exposure to ACTH and β-endorphin on the brain and behavior of rats [113] [114] [115] . The authors reported that fetal exposure to stress hormones increased their expression [116] and downregulated receptors in the brain [117] of these animals as adults.
Over the past 15 years or longer, the group has conducted prospective, longitudinal studies of over 800 mother/fetal dyads. The protocol for the assessment of prenatal exposure to maternal stress and stress hormones on fetal, infant and child development includes maternal Maternal psychosocial stress and demographic information is collected in parallel with infant assessments. Child neurodevelopment is assessed between 6 and 9 years of age with cognitive tests, measures of adjustment and brain imaging. The authors believe that it is essential to make multiple assessments during gestation and follow-up because these are critical periods both for the effects of programming on the nervous system and for the expression of subsequent behaviors. For instance, during gestation, organ systems may be most vulnerable during periods of rapid development. Furthermore, as cognitive functions come 'on line,' the authors may begin to detect delays that were not apparent previously; the effects of prenatal exposure to stress hormones on language areas cannot be detected before the child is able to talk. The authors have concluded from these studies that fetal exposures to elevated stress hormones of the HPA and placental axis and to maternal psychological stress are risk factors for adverse neurobehavioral outcomes [8, 111] . All of these studies described here include normative samples of healthy mothers and infants/ children. Furthermore, in all cases, the consequences of prenatal stress are present after considering postnatal influences, such as socioeconomic status (SES) and postnatal maternal stress, anxiety and depression.
In addition to the evaluation of natural variations in maternal stress and stress hormones, the authors have assessed the consequences of prenatal treatment with synthetic glucocorticoids. This approach takes advantage of a common clinical practice: administration of glucocorticoid treatment to women at risk of preterm delivery to promote fetal lung maturation. This model complements the understanding of the influence of natural variation in prenatal maternal stress hormones by testing the effect of administration of a high level of glucocorticoids on developmental trajectories. These studies are also important because this treatment is part of the standard of care for women in preterm labor and has resulted in millions of children being exposed to excess glucocorticoids during the prenatal period. Despite the beneficial effects of treatment for lung functioning and survival among preterm newborns, the long-term effects on human brain and behavioral development are not known. The authors believe that this approach provides important information about the impact of intrauterine exposure to excess glucocorticoids. A unique component of research is the inclusion of children who were born healthy and full term. This cohort is particularly important for two reasons: these children were exposed to a high dose of glucocorticoids without receiving commensurate medical benefits and the consequences of glucocorticoid treatment can be differentiated from the effects of preterm delivery.
The authors have demonstrated that prenatal glucocorticoid treatment suppresses growth [81] and alters postnatal HPA axis functioning in both preterm and full-term infants [82, 83, 118] . These alterations to biological systems during fetal development resulting from prenatal exposure to glucocorticoids may determine the neonate's ability to respond physiologically to stressors in the postnatal environment and may establish a trajectory of development associated with increased cortisol reactivity to stress and a greater risk for the development of behavioral inhibition and anxiety. Ongoing studies to follow these children will determine the persisting effects of prenatal glucocorticoid treatment for brain and behavior. Furthermore, these prospective studies will identify maternal/fetal dyads who are vulnerable to the negative consequences of glucocorticoid treatment because of the associated changes in maternal and placental physiology.
Maternal fight or flight system influences fetal behavior
Measures of fetal responses to external stimulation have been used to directly assess the developmental consequences of exposure to endocrine markers of stress [119] . The authors have reported that elevated placental CRH [51] or pituitary stress hormones [120] during the third trimester is associated with dampened fetal responses to a novel stimulus and delayed habituation to repeated stimulation. In a more recent study of programming influences on the fetus, the authors found that low CRH at 15 gestational weeks, but not later, predicted a more mature fetal heart rate pattern at 25 gestational weeks [121] . This is evidence that exposure to endocrine stress exerts programming influences on the developing fetal nervous system with possible consequences for the trajectory of development and for the risk of poor neurobiological health outcomes [111, 112] .
Neurological risk & GA: birth phenotype or intrauterine exposures?
The important and fertile initial studies introducing the programming hypothesis were retrospective and relied on birth phenotype, either birthweight or gestational length, as markers of intrauterine exposures. In these early studies, adult health outcomes were known, but birth outcomes were obtained from a review of old medical records. The well-known findings were that poor health was associated with adverse birth outcomes. It is well established and briefly described herein that adverse birth outcomes can result from numerous intrauterine complications and sources. It is also well known that adverse birth outcomes influence the course of infant and child development. Contemporary studies, including the authors' prospective projects, are focused on specific intrauterine conditions that influence (program) the fetus, and these conditions may or may not result in adverse birth outcomes. In every case, the authors' projects on the effects of intrauterine fetal exposures on neurodevelopmental outcome always adjust for gestational length and size at birth.
As described earlier, the human fetus detects maternal stress and can 'escape' or 'flee' from the inhospitable maternal host by accelerating the birth process, enlisting the same stress hormones as the tadpole does to escape threats to survival. The association between preterm labor/delivery and maternal plasma concentrations of CRH (and other hormones) and levels of stress in humans and has been examined in many published studies [122] . The general findings are that plasma CRH concentrations of women in preterm labor are significantly higher than those of gestational age-matched controls, and the rate of change of CRH over gestation is accelerated in women destined to deliver early [15] . Similarly, higher levels of stress and anxiety are associated with shorter gestational length [123] . Studies measuring CRH or stress at a single point during gestation produce equivocal findings because there are wide individual differences that can only be assessed with longitudinal designs, and because it is the trajectory of these biopsychological markers over gestation that best predicts length of gestation generally and not just preterm birth [14, 66] .
There are well-documented increases in infant and toddler mortality and morbidity associated with preterm birth, but there are other longer-term risks associated with abbreviated gestation. Retrospective studies have concluded that fetuses born early or small for GA are at greater subsequent risk for later cardiovascular disease, hypertension, hyperlipidemia, insulin resistance, non-insulin-dependent diabetes mellitus, obesity, higher serum cholesterol concentrations, shortened lifespan and other poor health outcomes [1, [124] [125] [126] [127] . The consequences of shortened gestation are not restricted to preterm birth, but rather are apparent across the full GA range [128] . New findings from the program indicate that there are neurological advantages in 6-10-year-old children associated with longer gestation even in full-term births (greater than 37 weeks) [19] . As reviewed earlier, elevated levels of placental CRH and other hormones are a significant risk factor for shortened gestation, and the authors believe that fetal exposures to these endocrine changes during pregnancy make an independent contribution to subsequent health outcomes typically associated with preterm birth.
Maternal fight or flight system influences stress, emotional regulation & the brain Neonates
Evidence from the project indicates that fetal exposure to maternal stress hormones exerts influences on the development of the fetal HPA axis that have consequences for neonatal functioning [129] . The authors reported that fetal exposure to maternal cortisol and psychosocial stress influences stress regulation in 24-hold neonates. Elevated maternal cortisol early in gestation and maternal psychosocial stress throughout gestation were associated with slower neonatal behavioral recovery from the painful stress of a heel-stick procedure. Elevated maternal cortisol during the second half of gestation was associated with a larger and more prolonged neonatal cortisol response to stress. These findings were consistent with evidence that prenatal exposure to synthetic glucocorticoids during the late second and early third trimester in healthy full-term infants were associated with an amplified cortisol response to stress [118] . These data are important because they indicate that prenatal exposure to glucocorticoids alters developmental trajectories of the fetal HPA axis, and these effects on the HPA axis are apparently independent of gestational length and before there is in an opportunity for postpartum influences. Moreover, these findings provide support that the timing of exposures during gestation determine the neonate's ability to respond behaviorally and physiologically to stressors in the postnatal environment. It is possible that neonates who are more reactive because of their prenatal exposure to stress hormones carry a greater risk for developmental and other health risks independent from birth outcome.
Infants
The authors have found that the association between prenatal psychobiological stress signals and greater behavioral reactivity persists throughout infancy. Elevated maternal cortisol and placental CRH during the third trimester independently predicted infants' reactivity to novel stimuli, indicating greater fearful temperament [130, 131] . Infants who are easily aroused by varied stimulation are more likely to become behaviorally inhibited as young children [132, 133] and result in higher risk for social anxiety in adolescence [134] . Thus, it is likely that prenatal exposure to elevated cortisol and placental CRH has direct implications for subsequent behavioral problems including increased risk for affective disorders. These longitudinal studies in which the authors have followed these infants into childhood support this hypothesis.
Children
Exposure to maternal psychological distress during gestation is associated with negative temperament at 2 years of age [135] . These recent data provide compelling evidence that the consequences of these intrauterine exposures persist and that they contribute to risk for anxiety disorders [136] . In this study of 178 mother/child dyads, the authors reported that prenatal exposure to elevated maternal cortisol, depression, perceived stress and pregnancyspecific anxiety was associated with increased anxiety symptoms in 6-9-year-old children.
The results of this study indicate that elevated maternal cortisol levels and maternal psychological distress during gestation are associated independently with childhood anxiety as long as 9 years later, and that this association could not be explained by critical prenatal or obstetric risk factors or by postnatal influences such as maternal psychological wellbeing and SES. Specifically, children who were exposed to elevated levels of maternal cortisol during gestation are significantly more likely to fall in the borderline or clinically significant range for anxiety (odds ratio: 2.1). The association between prenatal exposure to elevated maternal cortisol and child anxiety is consistent with experimental animal studies indicating lifelong consequences of prenatal exposure to elevated glucocorticoids [137, 138] , and with human studies that link maternal cortisol with increased fearful or reactive behavior during infancy [131, 139] . This project identifies prenatal risk factors associated with lasting consequences for child mental health. Importantly, the association between the prenatal risk factors and child outcomes described here cannot be explained by postnatal exposures such as SES or postnatal maternal psychological distress. These data raise the possibility that reducing maternal distress during the prenatal period will have long-term benefits for child wellbeing.
Exposure to maternal cortisol during gestation may influence the development of anxiety by modifying fetal development in regions such as the amygdalae [140, 141] that are particularly sensitive to excessive levels of glucocorticoids [142] and play a role in the regulation of anxious behavior [143] . Findings from animal models illustrate that prenatal stress exposures, including excess glucocorticoids, alter the density of cortisol receptors [144] and increase the production of CRH in the amygdalae [145, 146] . Furthermore, exposure to stress during the prenatal period is associated with an increase in amygdala volume [147] , suggesting a plausible mechanism by which prenatal cortisol may influence vulnerability to the development of anxiety.
In a recent study [148] , the authors evaluated the consequences of fetal exposure to maternal cortisol early in pregnancy on the volumes of the amygdala and hippocampus in 65 children. The authors found that higher maternal cortisol concentrations in early gestation were associated with a larger right amygdala volume and affective problems in girls at the age of 7 years. The magnitude of the effect was substantial; a one standard deviation increase in maternal cortisol was associated with a 6.4% increase in the size of the right amygdala. The current findings represent the first report linking maternal stress hormone levels in human pregnancy with subsequent volume of the amygdala and affective problems in childhood. The effect was significant after controlling for the effects of other pregnancy, birth and concurrent child and maternal characteristics, including maternal depression. Statistical modeling suggested that the association between maternal cortisol in early gestation and affective problems in girls is mediated by their cortisol-associated larger right amygdala.
Maternal fight or flight system influences cognition & brain development Neonates
In a previous study of 158 newborns within 24 h after birth, the authors found that fetal exposure to increased levels of maternal cortisol at 15 and 19 weeks gestation and increased levels of placental CRH at 31-weeks gestation were associated with significant decreases in newborn physical and neuromuscular maturation [148] . These effects were observed after adjusting for length of gestation, indicating that fetal exposure to stress hormones programs neonatal neuromuscular maturation independent of GA. These observations in the neonate provide strong support for fetal programming because the consequences of gestational exposures cannot be explained by postnatal influences such as quality of maternal care.
Infants
In a large study (125 subjects) of the cognitive consequences of fetal exposures to stress hormones, the authors reported that high levels of maternal cortisol early in pregnancy resulted in significantly lower scores on measures of mental development at 12 months of age [150] . Elevated maternal cortisol late in gestation, however, was associated with significantly better scores on measures of mental development. It is important to remember that the human fetus is partially protected from elevations of maternal cortisol early in pregnancy because it is oxidized and inactivated by the enzyme 11β-HSD2. However, 11β-HSD2 is only a partial barrier, which explains why maternal and fetal cortisol levels are correlated. Thus, synthesis and release of elevated levels of maternal cortisol exposes the fetus to concentrations that may have detrimental neurological consequences, especially when these exposures occur early in gestation. As described earlier, fetal exposure to elevated cortisol is necessary for maturation of the fetal nervous system and lungs as pregnancy advances towards term. Fetal exposure to cortisol during the third trimester is ensured by the sharp drop in 11β-HSD2, which allows a greater proportion of maternal cortisol to cross the placental barrier. These results indicate that gestational exposure to maternal stress hormones has a significant influence on the fetal nervous system with potentially long-term consequences for mental processes such as memory and attention and that these consequences are determined by the timing of exposure. Maternal psychological distress signals early in gestation were also associated with delays in mental development. Consistent with the observations for stress and emotional regulation, the consequences of psychological distress were independent from the effects of maternal cortisol [150] . These data indicate that exposure to maternal psychobiological distress early in gestation is associated with an increased risk for cognitive impairments.
Children
The authors report new findings that fetal exposure to maternal anxiety exerts persisting consequences on child cognition. High levels of maternal pregnancy-specific anxiety over the course of gestation were associated with lower inhibitory control in 6-9-year-old girls and poorer visuospatial working memory performance in both girls and boys. The findings are highly consistent with the observations during infancy and contribute to the literature supporting an association between prenatal anxiety and cognitive development. This study provides evidence about the persistence of this effect until middle childhood [151] .
The authors have shown that fetal exposure to maternal anxiety was related to specific changes in brain morphology of children independent of birth phenotype [152] . Specifically, maternal reports of anxiety about pregnancy early in gestation were associated with gray matter volume reductions in many areas of the brain that are associated with a variety of cognitive abilities. Specifically, prefrontal cortical areas that are responsible for executive functions such as reasoning, planning, attention, working memory and some aspects of language were reduced [153] . Moreover, structures in the medial temporal lobe were reduced, including areas connected to the hippocampus that constitute a medial temporal lobe memory system [154] . Reduced volume was observed in children whose mothers reported high levels of anxiety in the temporal polar cortex that is associated with social and emotional processing, including recognition and semantic memory [155, 156] . Reduction of volume in an auditory network [157] and in brain systems involved in language learning [158] was observed in children whose mothers reported high levels of anxiety early in gestation. The prospective longitudinal studies provide evidence that exposures to both maternal cortisol and maternal psychological distress early in gestation alter trajectories of brain development and increase risk for cognitive impairments, and that these effects persist at least into pre-adolescence.
Expert commentary
Exposure to biological markers of prenatal stress, especially related to the HPA and placental axis, is an emerging risk factor affecting human development and risk for disease. Exposure to stress at any time during human development can have serious and long-term consequences for physical and emotional health; however, the effects may be most harmful when they occur early during development. It has become apparent that during pregnancy, maternal stress threatens the fetal nervous system with serious consequences that result in a spiral of increasing risk of impairment and morbidity.
It is important to acknowledge that gestation does not proceed at a uniform rate but has critical periods when there are peak activities of specific events. Maternal hormones are in flux during pregnancy and so are enzymes and binding proteins that influence their activity. Despite these known effects, there still are very few longitudinal, prospective studies of the consequences for the human fetus of changes in the endocrine stress system during human pregnancy. Only with the implementation of prospective longitudinal studies of pregnancy will it be possible to determine the developmental consequences of gestational exposure to maternal stress and stress hormones.
To further complicate the ability to predict the effects of exposures to biological markers of stress on health outcomes is the fact that organogenesis follows a developmental pattern. Different organs develop at different times, and organs are most susceptible to organizing and disorganizing influences during periods of rapid development. The authors have focused on the development of the brain and have described the effects of gestational stress on neurological outcomes, but there are influences on other organs with different profiles of risk. It is equally important to recognize that skills and abilities (motor, language and so on) are exhibited at different times during infant and child development, and assessments must to be tailored to expected outcomes. All of these facts make it essential to conduct longitudinal studies with serial measures in order to determine accurately the risk of exposures on health outcomes. Studies of a single exposure at a single time or of a single outcome are the norm and are likely to provide an incomplete picture at best.
There is growing recognition that there are sexually dimorphic responses to stress and adversity [159] [160] [161] , including and perhaps especially associated with stress during the prenatal period [146, 162, 163] . The authors reported [164] that female fetuses displayed more mature startle responses than males at 31 and 36 gestational weeks, and were more sensitive to the effects of cortisol on the development of the startle response during this gestational period [165] , and that delayed neuromuscular development associated with fetal exposure to cortisol early in gestation and placental CRH late in gestation was confined to male neonates [149] . A reduction in brain volumes in children exposed to elevated maternal anxiety early in gestation, primarily, were observed in girls [111] . Results from the studies are consistent with those that report specific trajectories of development are determined by fetal sex [166, 167] and that sexually dimorphic risk of neurological impairment is associated with neonatal complications [168] .
Sexually dimorphic patterns in response to stress may be developed very early in gestation.
The female placenta appears to be more responsive to changes in glucocorticoid concentration than the male placenta, resulting in different patterns of growth [169] . Male fetuses invest in growth and not flexibility in response to adversity or stress. As the male fetus has not adjusted to early adversity and not conserved its resources, it is less able to adjust to later stress and is therefore at greater risk for morbidity and mortality. By contrast, the female placenta responds or adjusts to prenatal adversity in multiple ways (gene and protein changes), resulting in reduced growth. However, if exposed to stress that reduces nutrients and resources later in gestation, the female fetus has conserved its energy needs, which increases the probability of survival. Clearly, consideration of sex differences as early as fetal life is an important factor for determining risk for health outcomes. These differential responses of male and female fetuses to intrauterine signals probably contribute to sexually specific vulnerabilities to later health risk.
Five-year view
In recognition of the importance of early-life events for mental health, the National Institute of Mental Health (NIMH) advocates advancing the field of translational developmental neuroscience by identifying and understanding periods of development that exhibit the most dramatic transitions in both humans and model organisms. It was argued that particular attention should be paid to altered trajectories during periods of rapid developmental transition for the identification of individuals at risk for mental illness. As mental illnesses were defined as disorders of life trajectories that begin before birth it is critical to examine the complex processes that shape early-life neurodevelopmental trajectories and determine how these processes lead to vulnerabilities for cognitive and emotional disorders. The fetal period in the life cycle is unmatched by any other in growth and development, and it is the period in the human lifespan that is most vulnerable to both organizing and disorganizing influences. This priority of the NIMH will focus research in this rapidly expanding field in the next 5 years.
Among the questions that need to be addressed include understanding how various endocrine signals of stress interact to reach and influence the developing fetus. This review primarily focused on endocrine markers. However, vascular and immune exposures exert both independent and additive influences on fetal health and developmental outcomes. The precise mechanisms of communication between mother and fetus are undoubtedly complex and largely unknown, and in some cases, the most plausible candidates have been ruled out. This is a fertile area of research, and in the next 5 years, an understanding should emerge of how and by which mechanisms the fetal experience exerts lifelong influences on health and wellbeing.
The focus of most developmental research evaluating the consequences of early experience has been on the influence of post-natal experiences, such as nurturance and maternal sensitivity. Although there is growing evidence supporting the importance of the prenatal environment for neurobehavioral development, few studies have evaluated the joint role of the prenatal and early postnatal periods. Research in the next 5 years will advance the understanding of the modulating influences of the postnatal environment on prenatal experience. The predictive adaptive response (PAR) model [170] is an alternative to the programming hypothesis. Instead of assuming that risk for disease is the only outcome of fetal exposure to adversity, the PAR proposes that the developing organism makes adjustments based on the predicted postnatal environment. When the PAR does not match the environment (i.e., the prediction is inaccurate), the mismatch results in disease states. For example, a prescient fetus exposed to maternal depression will prepare for, and perhaps thrive, in a post-natal environment in which a mother is depressed and less able to provide emotional support [171] . However, that same fetus may have increased risk of impairment if the postnatal environment does not match the predicted one, even if it is supportive.
Key issues
• The developmental origins of disease or fetal programming model predict that early exposures to threat or adverse conditions have lifelong consequences that result in poor health outcomes.
• The basic premise of the fetal programming model of disease is that developing organisms play an active role in their own construction.
• A remarkable surveillance and response system has evolved so that the human fetus can detect threats to survival and adjust its developmental trajectory.
• The adaptive 'fight or flight' system is dramatically altered during pregnancy, including the massive changes in the endocrine system characterized by the doubling in size of the pituitary gland and the growth and development of the placenta, which becomes an active endocrine organ.
• Stress hormones increase adaptively over the course of human pregnancy; however, abnormal elevations can increase the risk for adverse birth outcomes and other health risks.
• The consequences of exposure to stress hormones for the developing fetus are determined by the timetable for fetal organogenesis, vast changes in maternal stress physiology across gestation and changes in placental physiology.
• A prospective, longitudinal research program has provided evidence that exposures to stress hormones have neurological consequences for the fetus, neonate, infant and child. The effects are observed in emotional and cognitive regulation and in distinctive patterns of brain structure.
• Male and female fetuses respond differently to gestational stress exposures. Female fetuses are more likely to alter their developmental trajectory in response to moderate stressors and thus are better able to survive subsequent stress.
• The fetal period in the life cycle is unmatched by any other in growth and development, and it is the period in the human lifespan that is most vulnerable to both organizing and disorganizing influences. It is anticipated that studies of the human fetus and the health consequences of exposures to markers of stress will become an area of intense research.
• The predictive adaptive response is an alternative to the programming model. The premise is that health risk is associated with the match between fetal and infant/child exposures rather than just exposures to adversity. It is assumed that developing organisms accurately preparing for future environments will thrive even if the future is hostile. Uniquely during primate pregnancy, cortisol stimulates the synthesis and release of placental corticotrophin-releasing hormone. These two hormones are important stress signals that can influence the timing of birth and alter the neurological development of the fetus. A: Adrenal gland; ACTH: Adrenocorticotropic hormone; CRH: Corticotrophin-releasing hormone; H: Hypothalamus; P: Pituitary gland; pCRH: Placental corticotrophin-releasing hormone.
